Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
2000 participants
OBSERVATIONAL
2007-06-30
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease
NCT03703856
Treatment of Language and Memory in Patients With Alzheimer's Disease
NCT00593372
Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies
NCT04699786
Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease
NCT00551161
The Evaluation and Follow-up of Individuals With Memory Disorder
NCT00001480
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Older Adults
Persons over age 60 Participants will complete the Memtrax memory screening test
Memtrax Memory screening test
Memory Screening test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Memtrax Memory screening test
Memory Screening test
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Major medical problems.
* Aversion to test-taking.
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
US Department of Veterans Affairs
FED
John Wesson Ashford Jr
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
John Wesson Ashford Jr
Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
J. Wesson Ashford Jr., MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Palo Alto Health Care System
Palo Alto, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ashford JW, Borson S. Primary care screening for dementia and mild cognitive impairment. JAMA. 2008 Mar 12;299(10):1132-3; author reply 1133-4. doi: 10.1001/jama.299.10.1132-b. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SU-06302009-2900
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.